glp 1 and 2 drugs New GLP-1 Guidelines for Type Diabetes in 2025 Best Med #2: GLP-1 Receptor
Description
MRI-PDFF fat fraction assessment revealed marked hepatic fat decreases of 57%-67% among survodutide recipients vs
[41] Bimagrumab shows a separate mechanism from GLP1R or GIPR agonism, instead targeting muscle cells
Patients commonly lose 35 kg on average, though individual responses vary considerably
36.8kg/m2), and lower hemoglobin A1c (HbA1c
The medications are also linked to improvements in chronic kidney disease and, potentially, for brain health
Prescribing, dispensing, and delivery are handled by an independent third-party partner, and there is a companion app to track injections, weight, and side effects
